AXGN Axogen Inc

Price (delayed)

$10.39

Market cap

$439.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$493.81M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
Axogen's net income has decreased by 44% YoY
Axogen's quick ratio has decreased by 38% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
42.28M
Market cap
$439.33M
Enterprise value
$493.81M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.29
Price to sales (P/S)
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.85
Earnings
Revenue
$128.2M
EBIT
-$30.69M
EBITDA
-$26M
Free cash flow
-$44.6M
Per share
EPS
-$0.74
Free cash flow per share
-$1.06
Book value per share
$2.42
Revenue per share
$3.05
TBVPS
$4.59
Balance sheet
Total assets
$196.08M
Total liabilities
$94.39M
Debt
$72.56M
Equity
$101.69M
Working capital
$83.18M
Liquidity
Debt to equity
0.71
Current ratio
4.52
Quick ratio
3.59
Net debt/EBITDA
-2.1
Margins
EBITDA margin
-20.3%
Gross margin
82.5%
Net margin
-24.7%
Operating margin
-24.4%
Efficiency
Return on assets
-15.6%
Return on equity
-29.2%
Return on invested capital
-14.2%
Return on capital employed
-17.8%
Return on sales
-23.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
-1.61%
1 week
6.56%
1 month
23.1%
1 year
-43.07%
YTD
10.89%
QTD
26.86%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$128.2M
Gross profit
$105.71M
Operating income
-$31.29M
Net income
-$31.64M
Gross margin
82.5%
Net margin
-24.7%
AXGN's operating margin has shrunk by 61% YoY
Axogen's operating income has plunged by 58% YoY and by 2.5% from the previous quarter
The company's net margin fell by 46% YoY
Axogen's net income has decreased by 44% YoY

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
4.29
P/S
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.85
The company's EPS fell by 37% YoY
AXGN's P/B is 66% below its 5-year quarterly average of 12.5 but 10% above its last 4 quarters average of 3.9
The equity has decreased by 14% YoY and by 2.1% QoQ
AXGN's P/S is 61% below its 5-year quarterly average of 8.7

Efficiency

How efficient is Axogen business performance
Axogen's ROE has plunged by 60% YoY and by 3.5% from the previous quarter
The company's return on sales has shrunk by 55% YoY
The ROA has decreased by 42% YoY
Axogen's return on invested capital has decreased by 28% YoY but it has increased by 2.1% QoQ

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 108% higher than the total liabilities
Axogen's quick ratio has decreased by 38% YoY and by 11% from the previous quarter
AXGN's current ratio is down by 31% year-on-year and by 8% since the previous quarter
The company's debt is 29% lower than its equity
The debt to equity has grown by 16% YoY
The equity has decreased by 14% YoY and by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.